Summary

The product Dianabol 50 mg, submitted by asteroidbiotech@proton.me, underwent independent testing to verify its composition and potency. The sample, associated with Task Number #52880, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control.

The analysis confirmed the presence of Methandienone with a measured concentration of 49.02 mg, closely aligning with the expected label claim of 50 mg. The testing process was initiated on 21 October 2024, the sample was received on 7 November 2024, and the analysis was completed on 15 November 2024.

While the test results indicate accurate dosing, it is essential to scrutinize manufacturer-submitted samples, as they may selectively present high-quality batches. Independent third-party testing remains a crucial tool for verifying the consistency of products available to consumers.


Detailed Report

Product Overview

Testing Details

Testing Results


Verification Details


Evaluation of Manufacturer-Submitted Testing

This analysis confirms that the tested Dianabol 50 mg batch closely aligns with its labeled dosage. However, caution should be exercised, as manufacturer-submitted samples may not fully represent the quality and consistency of all available products. The reliability of Janoshik Analytical is well-regarded, but further independent testing across multiple batches would strengthen these findings.


Conclusion

The test results indicate that Dianabol 50 mg contains 49.02 mg of Methandienone, demonstrating a minor variance of -1.96% from the labeled claim. While this suggests quality control is maintained, continued independent analysis is essential for consumer safety and harm reduction.


Disclaimer

This report is published for educational and harm reduction purposes. Manufacturer-submitted tests may contain biases, but they still provide valuable insights when critically analyzed alongside independent third-party results. Readers should use this information responsibly.